Stryker Corporation (SYK): Winslow Capital Management, LLC exited its position 440K shares
Winslow Capital Management, LLC exited its position in Stryker Corporation, per its Q2 2026 13F.
- 440K
- Prior-quarter shares · no longer reported
- Holdings as of
- Jun 30, 2026
- Filed
- Aug 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 26, 2019Insider · Their first buy on recordDirector purchased ~$13K of SYK shares in the open market
- Sep 12, 2019Insider · Bought outside the usual windowDirector purchased ~$2.4K of SYK shares in the open market
- May 12, 2020InsiderDirector purchased ~$7K of SYK shares in the open market
- Jun 12, 2020InsiderDirector purchased ~$557 of SYK shares in the open market
- Nov 22, 2022Insider · First insider buy since Jul 2020Director purchased ~$4.1K of SYK shares in the open market
- Mar 27, 2026CongressDisclosed sale of SYK — reported range $15,001 - $50,000
- Jun 2, 2026CongressDisclosed partial sale of SYK — reported range $1,001 - $15,000
- Jun 17, 2026Federal contract · $1.8M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $1.75M obligated to date
- Jun 30, 2026Federal contract · $5.6M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $5.6M obligated to date
- Jul 16, 2026Federal contract · $1.2M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $1.19M obligated to date
- Jul 22, 2026CongressDisclosed partial sale of SYK — reported range $1,001 - $15,000
- Jul 30, 2026Company filing · Form 8-K · ResultsReported its results
What came next
- Aug 18, 2026Insider · 2 peopleInsiders: 9 sales (~$101.0M)
- Aug 19, 2026FDARecall: REF:2B5ST Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/OPTIVIEW TECHNOLOGY & SLEEVE 5MM X 75MM
- Aug 19, 2026FDARecall: REF:B11LT Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/STABILITY SLEEVE 11X100MM
- Aug 19, 2026FDARecall: REF:B12LT Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/STABILITY SLEEVE 12X100MM
- Aug 19, 2026FDARecall: REF:B5LT Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/STABILITY SLEEVE 5X100MM
- Aug 19, 2026FDARecall: REF:B5ST Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/STABILITY SLEEVE 5X75MM
- Aug 19, 2026Insider · 1 personInsiders: 12 sales (~$17.0M)
- Aug 21, 2026InsiderOfficer sold ~$145K of SYK shares in the open market
- Sep 15, 2026Federal contract · $2.6M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $2.58M obligated to date
- Sep 16, 2026FDARecall: Triathlon Hinge Femoral Prep Tray. Catalog Number: 6543-6-514.
- Sep 16, 2026FDARecall: TS Femoral Prep Tray, Triathlon. Catalog Number: 6543-6-507.
- Sep 16, 2026FDARecall: TS Misc. Instruments Tray, Triathlon. Catalog Number: 6543-6-519.
- Sep 16, 2026FDARecall: TS Universal Baseplate Finishing Tray, Triathlon. Catalog Number: 6543-6-506.
- Sep 16, 2026Federal contract · $1.7M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $1.73M obligated to date
- Sep 17, 2026FDAFDA device clearance: Neptune® SafeAir® 10ft Smoke Evacuation Pencil, Square Coated, 70mm Blade, Push Button Switch (0703-046-100);Neptune® SafeAir® 10ft Smoke Evacuation Pencil, Sq…
- Sep 24, 2026FDARecall: Precision Pointer Electromagnetic (8000-050-001)
- Sep 30, 2026CongressDisclosed partial sale of SYK — reported range $1,001 - $15,000
- Oct 6, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Stryker Corporation (the “Company”) announced on October 6, 2026 that Kevin A. Lobo will resign from his role as Chief Executive Officer (“CEO”) of the Company on December 31, 2026 and transition to the role of Executive Chair of the Board of Directors of the Company (the “Board”), effective January 1, 2027 (the “CEO Transition”) and that Spencer S. Stiles, who currently serves as President and Chief Operating…”
- Oct 8, 2026FDAFDA device clearance: Sonopet iQ Series III Console (5700-050-000); Sonopet iQ+ Straight Handpiece (5500-260-000); Sonopet iQ+ 10mm iQ+ Blade (5500-26B-010); Sonopet iQ+ 20mm iQ+ Bl…
- Oct 9, 2026FDAFDA device clearance: Excelsior Reach Microcatheter
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Stryker Corporation
For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SYK page.
How this filing works
Explore the data
Common questions
What does this filing report about Stryker Corporation (SYK) stock?
Winslow Capital Management, LLC exited its position in Stryker Corporation, per its Q2 2026 13F. Held the prior quarter, no longer listed per its Q2 2026 13F.
When did it happen, and when was it made public?
Holdings as of: Jun 30, 2026. Filed: Aug 13, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Stryker Corporation recently?
For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days. They are listed on the SYK page.
Does this mean SYK stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Stryker Corporation
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
Everything OQRO holds on this company is on its SYK page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
